Reminyl

In the US, Reminyl is a member of the drug class cholinesterase inhibitors and is used to treat Alzheimer's Disease.

UK matches:

• Reminyl Oral Solution (Shire Pharmaceuticals Limited) (SPC)
• Reminyl Tablets (SPC)
• Reminyl XL 8mg, 16mg and 24mg prolonged release capsules (SPC)

Ingredient matches for Reminyl

Galantamine

Galantamine is reported as an ingredient of Reminyl in the following countries:

• Latvia


• Luxembourg

Galantamine hydrobromide (a derivative of Galantamine) is reported as an ingredient of Reminyl in the following countries:

• Antigua & Barbuda


• Argentina


• Aruba


• Australia


• Austria


• Bahamas


• Barbados


• Belgium


• Bermuda


• Brazil


• Canada


• Cayman Islands


• Chile


• Colombia


• Costa Rica


• Czech Republic


• Denmark


• Dominican Republic


• Ecuador


• El Salvador


• Estonia


• Finland


• France


• Germany


• Greece


• Grenada


• Guatemala


• Guyana


• Honduras


• Hong Kong


• Iceland


• Indonesia


• Ireland


• Israel


• Italy


• Jamaica


• Lithuania


• Malaysia


• Malta


• Mexico


• Netherlands


• Netherlands Antilles


• New Zealand


• Nicaragua


• Norway


• Oman


• Philippines


• Portugal


• Romania


• Russian Federation


• Saint Lucia


• Saint Vincent & The Grenadines


• Singapore


• Slovakia


• Slovenia


• South Africa


• Spain


• Suriname


• Sweden


• Switzerland


• Taiwan


• Thailand


• Trinidad & Tobago


• Turkey


• United Kingdom


• United States


• Vietnam

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.